Viewing StudyNCT00032799



Ignite Creation Date: 2024-05-05 @ 11:24 AM
Last Modification Date: 2024-10-26 @ 9:07 AM
Study NCT ID: NCT00032799
Status: COMPLETED
Last Update Posted: 2016-06-16
First Post: 2002-04-03

Brief Title: Safety and Efficacy of Natalizumab in the Treatment of Crohns Disease
Sponsor: Biogen
Organization: Biogen

Key Dates - Follows AllAPIJSON File Order

Start Date: 2001-12
Start Date Type: None
Primary Completion Date: 2003-09
Primary Completion Date Type: ACTUAL
Completion Date: 2003-09
Completion Date Type: ACTUAL
First Submit Date: 2002-04-03
First Submit QC Date: April 3 2002
Study First Post Date: 2002-04-04
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-06-14
Last Update Post Date: 2016-06-16
Last Update Post Date Type: ESTIMATED